Cambridge Biomedical, provider of customised assays for small and large molecules, biomarkers and diagnostics, has announced the appointment of Dr Linda Robbie, as Vice President of Scientific Affairs.
As Vice President of Scientific Affairs, Dr Linda Robbie will be a key member of the leadership team. She will direct all initiatives related to science and technology and the introduction of new products and services, serving as the scientific expert, interfacing with both clients and internal teams.
Brad Yount, President and CEO at Cambridge Biomedical, said: “We are thrilled to have Linda join our team.
"Her remarkable achievements, expertise and leadership experience will be an asset to the Cambridge Biomedical organisation and reinforces our commitment to providing scientific leadership, cutting-edge assays and exceptional service to our clients.”
Before joining Cambridge, Robbie served as Global Senior Director at Q2 Solutions Laboratories, a Quintiles-Quest Joint Venture, and was Senior Director of the Global Assay Development Laboratory at Quintiles Laboratories.
She was a research fellow at the University of Aberdeen and, after receiving the British Society for Haematology Research Fellowship, served as a research fellow at Harvard Medical School in Boston.
